Adverse Events

This report evaluates the quality of that evidence and provides a plain language review of the statistics regarding the efficacy of High-Potency Polymerized Cross-linked Sucralfate as well as the inherent limitation of some guideline-supported therapies.
As an oncology pharmacist in an ambulatory cancer clinic, in the course of a typical week, it is not unusual for me to counsel 25 to 30 new patients on chemotherapy regimens that they are about to receive (paying particular attention to adverse events [AEs]), and to be directly involved in the monitoring and management of countless other patients who present with side effects associated with their treatments.
Among the various types of treatment that a patient with cancer may undergo, chemotherapy is associated with the greatest concerns with respect to side effects.

Results 1 - 7 of 7

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
    Country
  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code